{"pmid":32433302,"title":"To a New Normal: Surgery and COVID-19 during the Transition Phase.","text":["To a New Normal: Surgery and COVID-19 during the Transition Phase.","Ann Surg","Cobianchi, Lorenzo","Pugliese, Luigi","Peloso, Andrea","Dal Mas, Francesca","Angelos, Peter","32433302"],"journal":"Ann Surg","authors":["Cobianchi, Lorenzo","Pugliese, Luigi","Peloso, Andrea","Dal Mas, Francesca","Angelos, Peter"],"date":"2020-05-21T11:00:00Z","year":2020,"_id":"32433302","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1097/SLA.0000000000004083","topics":["Prevention"],"weight":1,"_version_":1667342288220585985,"score":9.490897,"similar":[{"pmid":32441680,"title":"New Normal Terminology.","text":["New Normal Terminology.","The COVID-19 pandemic has required us to recognize a new normal and other additions to our general and clinical vocabulary. Some were preexisting terms that now have been broadened or changed during these unprecedented times. Others have helped to bring to light some of the issues or difficulties that healthcare professionals faced prior to this pandemic.","Clin J Oncol Nurs","Carr, Ellen","32441680"],"abstract":["The COVID-19 pandemic has required us to recognize a new normal and other additions to our general and clinical vocabulary. Some were preexisting terms that now have been broadened or changed during these unprecedented times. Others have helped to bring to light some of the issues or difficulties that healthcare professionals faced prior to this pandemic."],"journal":"Clin J Oncol Nurs","authors":["Carr, Ellen"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32441680","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1188/20.CJON.223","keywords":["covid-19","collaboration","dying alone","essential workers","granular data","healthcare disparities"],"weight":0,"_version_":1667523504838279168,"score":48.250202},{"pmid":32496948,"title":"COVID-19 and a New Normal?","text":["COVID-19 and a New Normal?","J Pastoral Care Counsel","Bard, Terry R","32496948"],"journal":"J Pastoral Care Counsel","authors":["Bard, Terry R"],"date":"2020-06-05T11:00:00Z","year":2020,"_id":"32496948","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1177/1542305020926831","weight":0,"_version_":1668712823976361985,"score":48.250202},{"pmid":32385458,"title":"What will be the new normal for the dental industry?","text":["What will be the new normal for the dental industry?","The COVID-19 situation has seen the cessation of all non-urgent dental care in the UK. Regular practice activity has come to a virtual standstill and the dental industry has seen a very significant reduction in its provision of products and services. There are differing government financial mitigations in place across dental practices for NHS and, to an extent private, activity, as well as for the dental industry. Dentistry is generally classified in the very high-risk category of aerosol production through many aerosol generating procedures (AGPs). To facilitate any move towards the resumption of widespread dental treatment, possibly without mass vaccination or the widespread use of antibody testing, the aerosol issue will need to be addressed and solved. From a dental industry perspective, equipment and product manufacturers and suppliers are building upon, and further developing, the industry's extremely close relationship and partnership with the dental profession, in order to develop and implement new ways of thinking and new approaches, products and techniques to protect patients and clinicians, focusing on a return to the more widespread provision of dentistry.","Br Dent J","Proffitt, Edmund","32385458"],"abstract":["The COVID-19 situation has seen the cessation of all non-urgent dental care in the UK. Regular practice activity has come to a virtual standstill and the dental industry has seen a very significant reduction in its provision of products and services. There are differing government financial mitigations in place across dental practices for NHS and, to an extent private, activity, as well as for the dental industry. Dentistry is generally classified in the very high-risk category of aerosol production through many aerosol generating procedures (AGPs). To facilitate any move towards the resumption of widespread dental treatment, possibly without mass vaccination or the widespread use of antibody testing, the aerosol issue will need to be addressed and solved. From a dental industry perspective, equipment and product manufacturers and suppliers are building upon, and further developing, the industry's extremely close relationship and partnership with the dental profession, in order to develop and implement new ways of thinking and new approaches, products and techniques to protect patients and clinicians, focusing on a return to the more widespread provision of dentistry."],"journal":"Br Dent J","authors":["Proffitt, Edmund"],"date":"2020-05-10T11:00:00Z","year":2020,"_id":"32385458","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1038/s41415-020-1583-x","locations":["GBR"],"countries":["United Kingdom"],"countries_codes":["GBR|United Kingdom"],"topics":["Prevention"],"weight":1,"_version_":1666340102092095488,"score":48.229813},{"pmid":32433284,"title":"Transitioning a Surgery Practice to Telehealth During COVID-19.","text":["Transitioning a Surgery Practice to Telehealth During COVID-19.",": The spread of COVID-19 has challenged practices across the United States to dramatically change inpatient and outpatient practices to focus on containing spread of the virus and accommodate the anticipated increase in volume of acute illness. Despite this transition, practices will need to continue to accommodate evaluation of newly diagnosed malignancies, routine postoperative visits, and acute postoperative issues. Building on an existing telemedicine framework, we aim to describe rapid transition in our outpatient care to a telehealth model in a general thoracic surgery practice during COVID-19.","Ann Surg","Grenda, Tyler R","Whang, Sung","Evans, Nathaniel R 3rd","32433284"],"abstract":[": The spread of COVID-19 has challenged practices across the United States to dramatically change inpatient and outpatient practices to focus on containing spread of the virus and accommodate the anticipated increase in volume of acute illness. Despite this transition, practices will need to continue to accommodate evaluation of newly diagnosed malignancies, routine postoperative visits, and acute postoperative issues. Building on an existing telemedicine framework, we aim to describe rapid transition in our outpatient care to a telehealth model in a general thoracic surgery practice during COVID-19."],"journal":"Ann Surg","authors":["Grenda, Tyler R","Whang, Sung","Evans, Nathaniel R 3rd"],"date":"2020-05-21T11:00:00Z","year":2020,"_id":"32433284","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1097/SLA.0000000000004008","locations":["United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1667342288286646272,"score":47.692364},{"pmid":32376171,"pmcid":"PMC7195118","title":"After the COVID-19 Pandemic: Returning to Normalcy or Returning to a New Normal?","text":["After the COVID-19 Pandemic: Returning to Normalcy or Returning to a New Normal?","The novel coronavirus, severe acute respiratory coronavirus 2 (SARS-CoV-2), pandemic has delivered a profound and negative impact on the United States. The suspension of elective surgeries including arthroplasty will have a lasting effect on all stakeholders including patients, physicians, and healthcare organizations within the US healthcare system. Resumption of elective hip and knee arthroplasty will need to be carefully focused. The purpose of this work is to address potential strategies, concerns, and regulatory barriers in restarting elective hip and knee arthroplasty in the United States.","J Arthroplasty","Zeegen, Erik N","Yates, Adolph J","Jevsevar, David S","32376171"],"abstract":["The novel coronavirus, severe acute respiratory coronavirus 2 (SARS-CoV-2), pandemic has delivered a profound and negative impact on the United States. The suspension of elective surgeries including arthroplasty will have a lasting effect on all stakeholders including patients, physicians, and healthcare organizations within the US healthcare system. Resumption of elective hip and knee arthroplasty will need to be carefully focused. The purpose of this work is to address potential strategies, concerns, and regulatory barriers in restarting elective hip and knee arthroplasty in the United States."],"journal":"J Arthroplasty","authors":["Zeegen, Erik N","Yates, Adolph J","Jevsevar, David S"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32376171","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.arth.2020.04.040","keywords":["covid-19","arthroplasty","economics","elective surgery","pandemic","recovery"],"locations":["United States","US","United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1666597097451814913,"score":41.22856}]}